PDF is scaled to 70%
a Warming Blanket
b Couverture de réchauffement
c Wärmedecke
d Coperta termica
e Manta térmica
f Warmtedeken
g Värmefilt
h Varmetæppe
i Varmeteppe
j Lämpöpeite
k Manta de aquecimento
l Κουβέρτα θέρμανσης
m Koc ogrzewający
n Melegítőtakaró
o Vyhřívaná přikrývka
a Adult Underbody Warming Blanket - Model 54500
INSTRUCTIONS FOR USE
Indications for Use
The 3M™ Bair Hugger™ Temperature Management System is intended
to prevent and treat hypothermia. In addition, the temperature
management system can be used to provide patient thermal comfort
when conditions exist that may cause patients to feel too warm or too
cold. The temperature management system can be used with adult and
pediatric patients.
• NOT STERILE.
•
Contraindications, Warnings and Cautions
Explanation of Signal Word Consequences
WARNING:
Indicates a hazardous situation which, if not avoided, could result in
death or serious injury.
CAUTION:
Indicates a hazardous situation which, if not avoided, could result in
minor or moderate injury.
CONTRAINDICATION: To reduce the risk of thermal injury:
• Do not apply heat to lower extremities during aortic
cross-clamping. Thermal injury may occur if heat is applied to
ischemic limbs.
WARNING: To reduce the risk of thermal injury:
• Do not treat patients with the Bair Hugger warming unit hose
alone. Always attach the hose to a Bair Hugger warming blanket
before providing warming therapy.
• Do not allow the patient to lie on the warming unit hose.
• Do not allow the warming unit hose to directly contact the
patient's skin during warming therapy.
• Do not leave neonates, infants, children and other vulnerable
patient populations unattended during warming therapy.
• Do not leave patients with poor perfusion unmonitored during
prolonged warming therapy.
• Do not place the non-perforated side of the warming blanket
on the patient. Always place the perforated side (with the small
holes) directly in contact with the patient's skin.
• In the operating room, do not use this warming blanket with
any device other than a Bair Hugger 500 series, 700 series or
675 warming unit.
• Do not use a Bair Hugger 200 series warming unit in the
operating room
• Do not use a Bair Hugger 800 series patient adjustable warming
unit with any Bair Hugger warming blanket.
• Do not continue warming therapy if the red Over-temp indicator
light illuminates and the alarm sounds. Unplug the warming unit
and contact a qualified service technician.
p Ohrievacia deka
q Grelna odeja
r Soojendav tekk
s Sasilšanas sega
t Atšilimo antklodė
u Pătură încălzitoare
v Обогревающее одеяло
x Pokrivač za zagrijavanje
y Затоплящо одеяло
z Deka za grejanje
1 Isıtma Battaniyesi
4
7 ﺑﻄﺎﻧﻴﺔ ﺗﺪﻓﺌﺔ
0 Batanije për ngrohje
[ ќебе за затоплување
• If a securement device (i.e. safety strap, tape) is used, ensure the
warming channels are not occluded.
• Do not place the warming blanket directly over a dispersive
electrode pad.
WARNING: To reduce the risk of patient injury or death due to
altered drug delivery:
• Do not use a warming blanket over transdermal
medication patches.
WARNING: To reduce the risk of injury due to interference
with ventilation:
• Do not allow the warming blanket or head drape to cover
the patient's head or airway when the patient is not
mechanically ventilated.
WARNING: To reduce the risk of injury due to patient falls:
• Do not use a warming blanket to transfer or move the patient.
CAUTION: To reduce the risk of cross-contamination:
• This warming blanket is not sterile and is intended for single
patient use ONLY. Placing a sheet between the warming blanket
and the patient does not prevent contamination of the product.
CAUTION: To reduce the risk of fire:
• This product is classified as Class I Normal Flammability
as defined by the Consumer product Safety Commission's
flammable fabric regulation, 16 CFR 1610. Follow standard safety
protocols when using high intensity heat sources.
CAUTION: To reduce the risk of thermal injury:
• Do not use if primary packaging has been previously opened or
is damaged.
CAUTION: To reduce the risk of thermal injury, hyperthermia
or hypothermia:
• 3M recommends continuously monitoring core temperature. In
the absence of continuous monitoring, monitor the temperature
of patients who are incapable of reacting, communicating and/or
who cannot sense temperature a minimum of every 15 minutes or
according to institutional protocol.
• Monitor cutaneous responses of patients who are incapable
of reacting, communicating and/or who cannot sense
temperature a minimum of every 15 minutes or according to
institutional protocol.
• Adjust air temperature or discontinue therapy when the
therapeutic goal is reached, if elevated temperatures are
recorded or if there is an adverse cutaneous response in the
warmed area.
Internal Use